Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome
Copyright policy )Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome
AbstractCreutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine.
neuroleptic malignant syndrome, Medicine (General), R, Case Report, quetiapine, R5-920, atypical antipsychotic medications, magnetic resonance imaging, Medicine, Creutzfeldt‐Jakob disease, electroencephalography
neuroleptic malignant syndrome, Medicine (General), R, Case Report, quetiapine, R5-920, atypical antipsychotic medications, magnetic resonance imaging, Medicine, Creutzfeldt‐Jakob disease, electroencephalography
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).3 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!